Azilect Market

Azilect(Rasagiline) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.

Azilect Market contains market size and forecasts of Azilect in global, including the following market information:

• Global Azilect Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Azilect Market Sales, 2017-2022, 2023-2028, (M Pcs)
• Global top five Azilect companies in 2021 (%)

The global Azilect market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

0.5 mg/Pcs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Azilect include Teva Pharmaceutical, Lundbeck, Sun Pharmaceutical, Apotex, Taj Pharma, Mylan, Takeda Pharmaceutical, Sandoz and Intas Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Azilect manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Azilect Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Azilect Market Segment Percentages, by Type, 2021 (%)

• 0.5 mg/Pcs
• 1 mg/Pcs

Global Azilect Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Azilect Market Segment Percentages, by Application, 2021 (%)

• Under 40 Years Old
• 40-65 Years Old
• Above 65 Years Old

Global Azilect Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Azilect Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Azilect revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Azilect revenues share in global market, 2021 (%)
• Key companies Azilect sales in global market, 2017-2022 (Estimated), (M Pcs)
• Key companies Azilect sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva Pharmaceutical
• Lundbeck
• Sun Pharmaceutical
• Apotex
• Taj Pharma
• Mylan
• Takeda Pharmaceutical
• Sandoz
• Intas Pharmaceuticals
• Natco Pharma
• Ajanta Pharma
• Orchid Pharma
• Alkem Laboratories